United States of America | BCH-RA-US-114115 | Risk Assessment generated by a regulatory process | Biosafety Clearing-House

Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-US-114115-1   |   PDF   |   Print   |  
last updated: 13 Dec 2018
General Information
Biotechnology Consultation Memorandum of Video-Conference BNF No. 000025
EN
Risk assessment details
  • CGN-89111-8 - High oleic acid canola
    | Monsanto (Calgene) | Production of medical or pharmaceutical compounds (human or animal) (Omega-3 fatty acids (e.g. DHA)), Resistance to antibiotics (Kanamycin)
Additional information
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 2